MWG Management
Latest statistics and disclosures from MWG Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BEAM, LYEL, PRME, and represent 100.00% of MWG Management's stock portfolio.
- Added to shares of these 1 stock: LYEL (+$16M).
- Started 1 new stock position in LYEL.
- Reduced shares in these 1 stock: Lyell Immunopharma (-$8.9M).
- Sold out of its position in Lyell Immunopharma.
- MWG Management was a net buyer of stock by $7.5M.
- MWG Management has $81M in assets under management (AUM), dropping by 56.69%.
- Central Index Key (CIK): 0001845151
Tip: Access up to 7 years of quarterly data
Positions held by MWG Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for MWG Management
MWG Management holds 3 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Beam Therapeutics (BEAM) | 67.7 | $55M | 2.3M | 24.27 |
|
|
| Lyell Immunopharma Com New (LYEL) | 20.1 | $16M | NEW | 1.0M | 16.24 |
|
| Prime Medicine (PRME) | 12.2 | $9.9M | 1.8M | 5.54 |
|
Past Filings by MWG Management
SEC 13F filings are viewable for MWG Management going back to 2020
- MWG Management 2025 Q3 filed Nov. 12, 2025
- MWG Management 2025 Q2 filed Aug. 14, 2025
- MWG Management 2025 Q1 filed May 13, 2025
- MWG Management 2024 Q4 filed Feb. 14, 2025
- MWG Management 2024 Q3 filed Nov. 8, 2024
- MWG Management 2024 Q2 filed Aug. 13, 2024
- MWG Management 2024 Q1 filed May 14, 2024
- MWG Management 2023 Q4 filed Feb. 14, 2024
- MWG Management 2023 Q3 filed Nov. 14, 2023
- MWG Management 2023 Q2 filed Aug. 14, 2023
- MWG Management 2023 Q1 filed May 15, 2023
- MWG Management 2022 Q4 filed Feb. 14, 2023
- MWG Management 2022 Q3 filed Nov. 14, 2022
- MWG Management 2022 Q2 filed Aug. 15, 2022
- MWG Management 2022 Q1 filed May 16, 2022
- MWG Management 2021 Q4 filed Feb. 14, 2022